Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)

SHE:300970 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	223.04	110.27	-47.57	30.35	78.25	15.5
Depreciation & Amortization	216.32	199.37	167.98	133.58	98.99	84.49
Other Amortization	0.62	0.65	0.23	0.27	0.26	0.02
Loss (Gain) From Sale of Assets	1.78	2.15	1.48	10.89	1.33	0.26
Asset Writedown & Restructuring Costs	8.3	0.67	0.4	-0.09	0.36	0.65
Loss (Gain) From Sale of Investments	-0.25	-	-0.09	-0.37	-4.2	-2.25
Other Operating Activities	27.83	24.69	26.1	13.23	5.43	4.61
Change in Accounts Receivable	2.23	3.3	-0.19	-5.27	20.71	-22.5
Change in Inventory	-56.77	-28.93	-15.18	-31.12	-52.48	-24.1
Change in Accounts Payable	40.17	33.06	2.72	12.84	30.61	26.39
Change in Other Net Operating Assets	0.08	0.08	1.91	2.36	0.6	-
Operating Cash Flow	463.34	345.31	137.8	166.67	179.84	83.08
Operating Cash Flow Growth	222.93%	150.59%	-17.32%	-7.32%	116.46%	-58.27%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-116.62	-123.12	-268.22	-224.15	-407.91	-204.09
Sale of Property, Plant & Equipment	0.11	0.09	0.06	1.34	0.13	-
Investment in Securities	-	-	-	99.7	398.12	-441.64
Other Investing Activities	0.25	-	-0.08	0.54	4.37	2.02
Investing Cash Flow	-116.26	-123.03	-268.24	-122.58	-5.29	-643.72

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Long-Term Debt Issued	-	149.47	251.03	75.26	141.7	169.66
Long-Term Debt Repaid	-	-155.53	-135.46	-129.56	-157.07	-55.78
Net Debt Issued (Repaid)	-44.04	-6.06	115.57	-54.3	-15.37	113.88
Issuance of Common Stock	28.26	25.76	24.66	16.96	-	609.28
Repurchase of Common Stock	-	-	-30.01	-	-	-
Common Dividends Paid	-70.93	-11.54	-33.55	-35.55	-2.69	-35.77
Other Financing Activities	-18.96	-1.38	4.01	6.5	4.1	-7.69
Financing Cash Flow	-105.67	6.78	80.67	-66.39	-13.97	679.7

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Foreign Exchange Rate Adjustments	-	-	-	-	-	0
Net Cash Flow	241.4	229.06	-49.77	-22.3	160.59	119.07

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	346.72	222.19	-130.42	-57.48	-228.07	-121.01
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	23.31%	17.20%	-12.64%	-5.77%	-30.34%	-20.93%
Free Cash Flow Per Share	2.23	1.44	-0.86	-0.38	-1.50	-0.84
Levered Free Cash Flow	213.22	131.86	-106.77	-48.42	-255.83	-174.72
Unlevered Free Cash Flow	223.2	141.84	-99.78	-42.96	-254.15	-172.32

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Income Tax Paid	1.05	0.85	0.9	1.36	2.61	0.2
Change in Working Capital	-14.3	7.52	-10.74	-21.2	-0.57	-20.2

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error